The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 13, 2019
Filed:
Aug. 09, 2018
Applicant:
Invista North America S.á R.l., Wilmington, DE (US);
Inventors:
Alex Van Eck Conradie, Eaglescliffe, GB;
Adriana Leonora Botes, Rosedale East, GB;
Assignee:
INVISTA NORTH AMERICA S.A R.L., Wilmington, DE (US);
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C08L 77/12 (2006.01); C08G 69/26 (2006.01); C07C 227/32 (2006.01); C08G 69/08 (2006.01); C07C 227/18 (2006.01); C07C 221/00 (2006.01); C07C 213/02 (2006.01); C07C 209/68 (2006.01); C12N 9/04 (2006.01); C12P 7/42 (2006.01); C12N 9/88 (2006.01); C12P 7/18 (2006.01); C12N 9/10 (2006.01); C12N 9/02 (2006.01); C12N 15/52 (2006.01); C12P 13/00 (2006.01);
U.S. Cl.
CPC ...
C08L 77/12 (2013.01); C07C 209/68 (2013.01); C07C 213/02 (2013.01); C07C 221/00 (2013.01); C07C 227/18 (2013.01); C07C 227/32 (2013.01); C08G 69/08 (2013.01); C08G 69/26 (2013.01); C12N 9/0006 (2013.01); C12N 9/0008 (2013.01); C12N 9/1096 (2013.01); C12N 9/88 (2013.01); C12N 15/52 (2013.01); C12P 7/18 (2013.01); C12P 7/42 (2013.01); C12P 13/001 (2013.01); C07B 2200/07 (2013.01); C12Y 101/01061 (2013.01); C12Y 102/99006 (2013.01); C12Y 206/01018 (2013.01); C12Y 401/01015 (2013.01); C12Y 401/01071 (2013.01);
Abstract
This document describes biochemical pathways for producing 4-hydroxybutyrate, 4-aminobutyrate, putrescine or 1,4-butanediol by forming one or two terminal functional groups, comprised of amine or hydroxyl group, in a C5 backbone substrate such as 2-oxoglutarate or L-glutamate.